Deal spread dominates weak fundamentals
- The GTLS setup is mainly a merger arbitrage trade tied to Baker Hughes buying Chart for $210.00 per share in cash.
- Chart stockholders approved the merger on October 6, 2025, so the main remaining issue in the filings was regulatory approval.
- First-quarter 2026 sales fell 11.7% year over year to $884.8 million, with declines in every segment.
- If the deal fails, the stock could lose the deal support and reprice around weaker standalone results.
- July news reports say the deal has closed, but the internal thesis still treats confirmation of close as the key point to verify.
A deal stock first
The investment case is not mainly about guessing how many tanks, heat exchangers, or service jobs Chart sells next year. It is about the pending all-cash merger with Baker Hughes at $210.00 per share. That makes GTLS a merger arbitrage name, which means buyers are betting on the gap between the market price and the deal price closing.
The bull case is simple. The merger receives the remaining approvals and closes, letting holders collect the spread to the $210.00 cash price. Stockholder approval is already done, based on the October 6, 2025 vote disclosed by the company.
The bear case is sharper now because the standalone business weakened. In the first quarter of 2026, sales fell 11.7% from the prior year to $884.8 million, and the company said sales were down in each segment. If regulators block the merger, or if another closing condition fails, the stock could fall toward a value based on those weaker fundamentals.
There is one current tension to watch. July news reports say Baker Hughes completed the Chart acquisition, while the internal company thesis on file still frames GTLS as pending and dependent on formal closing. The page therefore treats the close confirmation as the near-term item to verify rather than changing the whole thesis without a company filing update in the thesis record.
Cold gear for gas molecules
Chart designs, engineers, and manufactures equipment that handles gases and liquids at very low temperatures. These systems help move, store, heat, cool, and process molecules such as LNG, hydrogen, biogas, helium, and carbon dioxide.
The company makes money by selling equipment and full solutions, then earns more from repair, service, monitoring, leasing, and maintenance. That service side matters because it can be more repeatable than a large project sale.
Chart sells into many markets, including industrial gas, LNG, data centers, traditional energy, space, chemicals, infrastructure, nuclear, marine, food and beverage, and power generation. This gives the company many ways to win orders, but it also means project timing can swing results.
Right now, the business model matters most as downside protection if the deal does not close. The latest quarter did not help that case, because sales and profitability both weakened.
What Chart sells
LNG equipment
Chart supplies heat transfer and cryogenic systems used in the LNG supply chain. This is a core market, but it can depend on large energy project timing.
Repair, service, and leasing
This business repairs, services, and leases cryogenic equipment. It was the largest segment in the first quarter of 2026 at 31.5% of sales.
Hydrogen and clean fuels
Chart sells equipment used in hydrogen and biogas applications. These markets could grow over time, but they remain tied to customer investment cycles and policy support.
Carbon capture and CO2 systems
The company provides equipment for CO2 capture and handling. This fits Chart's clean industrial focus, but adoption can move slowly.
Industrial gas tanks
Cryo Tank Solutions serves industrial gas customers with storage and transport equipment. It was the smallest reportable segment in the first quarter of 2026.
Water treatment systems
Chart also sells technology for water treatment. This adds another end market, though it is less central to the merger thesis than LNG, service, and cryogenic gas systems.
First-quarter sales mix
Segment shares use Chart's three months ended March 31, 2026 sales disclosure. Sales declined in every segment versus the prior-year quarter, so the mix does not show a clean growth pocket.
What could break the setup
Regulatory approval delay or denial
High impact · Medium oddsThe merger still depends on required regulatory approvals in the internal thesis. Management said reviews were still underway in certain jurisdictions and that the timing could evolve. A delay can reduce the return for arbitrage buyers, while a denial could break the deal.
Deal break downside
High impact · Medium oddsIf the merger fails, GTLS would lose the support of the $210.00 cash offer. The standalone company just reported first-quarter sales down 11.7% year over year, with weaker profitability. That makes the downside case worse than it was before.
Termination payments
High impact · Low oddsThe merger agreement includes a $250 million termination fee payable by Chart in specific cases. Chart may also need to reimburse a $258 million payment Baker Hughes made on its behalf. Those costs would matter more if the company had to stand alone after a failed deal.
Leadership change during the deal
Medium impact · Medium oddsChart's former President and CEO resigned effective January 6, 2026, and Gerald F. Vinci became President the same day. A leadership change during a merger can add execution risk. It can also make it harder to keep employees, customers, and integration plans steady.
Post-filing close confirmation gap
Medium impact · Medium oddsJuly news reports say the Baker Hughes deal has closed, but the internal thesis record still treats the merger as pending. That creates a timing gap between market reports and the thesis file. If the close is formally reflected in the company record, GTLS may no longer trade as a normal public stock.
In one breath
Why is GTLS treated as a merger arbitrage stock?
Baker Hughes agreed to buy Chart for $210.00 per share in cash. A merger arbitrage investor is mainly betting that the deal closes and the stock price moves to the cash offer price.
What does Chart Industries actually make?
Chart makes equipment and systems for handling gases and liquids, often at very low temperatures. Its products are used in LNG, hydrogen, biogas, CO2 capture, industrial gases, water, and other industrial markets.
What is the biggest risk for Chart shareholders?
The biggest risk is that the Baker Hughes deal fails or is delayed. If that happens, investors would have to value Chart on its standalone business, which weakened in the first quarter of 2026.
Did Chart shareholders approve the Baker Hughes deal?
Yes. Chart disclosed that stockholders approved and adopted the merger agreement on October 6, 2025. The internal thesis then focused on regulatory approvals and closing conditions.